申请人:Bloxham Jason
公开号:US20080261952A1
公开(公告)日:2008-10-23
A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.
通过向需要此类治疗的受试者施用有效量的芳基脲CB-1受体调节化合物来治疗与CB-1受体相关的疾病,尤其是肥胖症的方法。